Icotinib Versus Placebo as Adjuvant Therapy in EGFR-mutant Lung Adenocarcinoma
Clinical trial NCT02125240 · UNKNOWN
Trial details
- NCT number
- NCT02125240
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2018-12-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.